High risk for recurrent thromboembolism

Bridging therapy after cessation or reversal of anticoagulation is needed as soon as the INR is in the subtherapeutic range (INR < 2). There is no bridging recommended if the patient is already taking a direct anticoagulant drug (DOAC).

Start bridging anticoagulation with:

IV UFH
or <%= buttons %>